CHILD PSYCHIATRY & HUMAN DEVELOPMENT, published by Springer, stands at the forefront of research in the fields of developmental and educational psychology, pediatrics, perinatology, and child psychiatry. With an ISSN of 0009-398X and an E-ISSN of 1573-3327, this esteemed journal has been a vital resource for academics since its inception in 1970. Currently ranked in the Q1 category across its multiple relevant disciplines, it illustrates a significant impact with its Scopus rankings, placing it within the top 13% for pediatrics and child health and the top 18% for developmental psychology. Its comprehensive scope ensures that leading-edge studies, reviews, and discourse are accessible, contributing greatly to the understanding of mental health and developmental processes in children. With no open access option, the journal maintains a commitment to high-quality, peer-reviewed content that is invaluable for researchers, healthcare professionals, and students alike, as they strive to advance their knowledge and practices in child psychology and human development.

The BULLETIN OF THE MENNINGER CLINIC, an esteemed publication of GUILFORD PUBLICATIONS INC, has been a pivotal resource in the fields of Clinical Psychology and Psychiatry since its inception in 1945. With ISSN 0025-9284 and E-ISSN 1943-2828, this journal is recognized for its commitment to advancing knowledge and practices in mental health. Indexed in Scopus with respectable rankings across various categories, it stands in the Q3 quartile for both Clinical Psychology and Psychiatry and Mental Health, indicating its role as a significant contributor to academic discourse. Although it operates under a subscription model, the journal features a broad spectrum of peer-reviewed articles, case studies, and research findings that are essential for professionals, researchers, and students dedicated to understanding and improving mental health care. The BULLETIN OF THE MENNINGER CLINIC serves as a vital platform for interdisciplinary dialogue, fostering innovative approaches and methodologies that shape the future of mental health treatment and research.

PSYCHIATRIE DE L ENFANT is a distinguished academic journal published by PRESSES UNIV FRANCE, focusing on the significant realm of child psychiatry and developmental psychology. With its ISSN 0079-726X and E-ISSN 2102-5320, this journal provides a platform for researchers, practitioners, and educators to explore various topics surrounding mental health in children. Although the coverage in Scopus has been discontinued since 2018, with ranks highlighting its placement in the Developmental and Educational Psychology and Psychiatry and Mental Health categories, the journal's contributions remain pivotal for professionals aiming to advance their understanding of child mental health. Though it does not currently offer open access, the journal invites rigorous studies, clinical insights, and theoretical discussions that are crucial for the evolution of child psychiatry. As such, PSYCHIATRIE DE L ENFANT plays an essential role in shaping future research and practices in the field.

Child and Adolescent Psychiatry and Mental Health, published by BMC, is a premier open access journal dedicated to advancing the field of mental health and psychiatric care for children and adolescents. Since its inception in 2007, the journal has fostered a global dialogue among researchers, clinicians, and policy makers by disseminating high-quality research that addresses critical issues in child and adolescent psychiatry. With an impressive Q1 ranking in Pediatrics, Perinatology and Child Health and Psychiatry and Mental Health, it holds a significant position within the academic community, ranking 28th out of 330 in its field. This standing enhances its visibility and relevance, appealing to a wide range of professionals interested in evidence-based practices. As an open access journal, it ensures that research is freely accessible to those who need it most, facilitating greater collaboration and progress. The journal is committed to publishing diverse articles that span various aspects of mental health, including preventive measures, therapeutic interventions, and the intersection of mental health with social determinants. Researchers, practitioners, and students alike will find valuable insights and innovations within its pages, making it an indispensable resource in the field.

Current Psychiatry Research and Reviews is an innovative open access journal dedicated to the dynamic field of psychiatry and mental health. Published by Bentham Science Publishers Ltd, this journal provides a platform for researchers and practitioners to disseminate pivotal findings, reviews, and advancements in psychiatric research. While the journal currently holds a Q4 status in the Psychiatry and Mental Health category, it seeks to elevate standards with interdisciplinary contributions aimed at improving patient outcomes and treatment methodologies. With a publication window spanning from 2019 to 2024, the journal aims to enhance global discussions in mental health sciences, encouraging submissions that explore evidence-based practices, innovative therapeutic techniques, and the epidemiology of mental health disorders. The journal's address in the Netherlands positions it strategically within Europe’s vibrant research community, making it an essential resource for researchers, professionals, and students alike who are invested in the evolution of psychiatric science.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, published by Vandenhoeck & Ruprecht GmbH & Co KG, is a prominent journal in the fields of psychosomatic medicine and psychotherapy. With a rich history spanning from 1996 to 2024, this journal serves as a vital platform for disseminating research and advancements within applied psychology, clinical psychology, and psychiatry. The journal is categorized in the Q3 quartile for 2023 across various disciplines, reflecting its ongoing relevance and contribution to the scientific community. Despite not currently offering open access, it remains accessible to researchers and professionals through institutional subscriptions and libraries. By bridging the gap between empirical research and clinical practice, ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE enhances the understanding of psychological processes and their implications for mental health, making it an indispensable resource for academics, practitioners, and students dedicated to the advancement of psychosomatic health.

NEUROPSYCHIATRIE, published by SPRINGER WIEN, is a prestigious journal operating from Austria that focuses on advancing the fields of Clinical Psychology and Psychiatry. With an ISSN of 0948-6259 and an E-ISSN of 2194-1327, NEUROPSYCHIATRIE has garnered attention within the academic community, exemplified by its classification in the Q2 category for Clinical Psychology and Q3 for Psychiatry and Mental Health as of 2023. The journal provides a platform for the dissemination of innovative research findings and clinical insights, critical for professionals dedicated to addressing complex neuropsychiatric conditions. Researchers aspiring to explore the intricacies of mental health will find a wealth of knowledge, as evidenced by its Scopus rankings—115th in Clinical Psychology and 260th in Psychiatry and Mental Health—indicating its influential position. Covering a wide range of topics from neurobiology to psychotherapeutic interventions, NEUROPSYCHIATRIE acts as a vital resource, making significant contributions to enhancing clinical practices and fostering interdisciplinary collaborations in mental health.

Journal of Psychiatric Practice, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of psychiatry and mental health. With a focus on evidence-based clinical practice, the journal has been a respected resource since its inception, providing a platform for a wide range of articles, including original research, reviews, and case reports from 1997 to the present. As of 2023, it holds a Q3 ranking in Psychiatry and Mental Health, reflecting its influential role in the academic community. The Journal is aimed at researchers, mental health professionals, and students, promoting the dissemination of essential knowledge and innovative practices. Subscribers benefit from the latest findings and discussions in the field while contributing to the ongoing advancements in psychiatric care. Although not classified as open access, the journal ensures wide accessibility to its valuable content, further solidifying its commitment to the mental health discipline.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY is a premier academic journal published by Elsevier Science Inc, dedicated to advancing the fields of child and adolescent psychiatry and developmental psychology. With an impressive impact factor ranking it in the Q1 category of both Developmental and Educational Psychology and Psychiatry and Mental Health, this journal serves as a critical platform for researchers and clinicians seeking to address the mental health challenges faced by younger populations. Since its inception in 1962, it has consistently provided a diverse range of scholarly articles that contribute to evidence-based practices in the field, making it an indispensable resource for the global community. The journal is accessible through various academic databases, ensuring that cutting-edge research reaches those who need it most. As we look ahead to its ongoing trajectory from 1987 to 2024, the JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY continues to be at the forefront of mental health research, fostering innovation and collaboration among professionals and students alike.